Heron Therapeutics(DE:AXD2)
€0.34+0.01 (+1.52%)
DE:AXD2
Heron Therapeutics earnings date
€0.34
At close:+0.01 (+1.52%)
Heron Therapeutics (AXD2) Q3 2022 Earnings Report
4 Followers
DE:AXD2 Q3 2022 EPS Results
- Actual EPS
- -EUR 0.34
- Consensus EPS
- -EUR 0.34
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.46
DE:AXD2 Q3 2022 Revenue Results
- Actual Revenue
- EUR 23.78M
- Expected Revenue
- EUR 24.14M
- Beat/Miss
- Missed by -EUR 360.83K
- YoY Revenue Growth
- +14.32%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/08/2022
- Time
- TBA
- Conference Call
- Tuesday, November 8, 2022
DE:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:AXD2 Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.03- | -0.02 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.02-0.03 | -0.09 | 70.00% (+0.06) | |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.03 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.04 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.09 | -0.03 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.04) | |
| May 06, 2025 | 2025 (Q1) | -0.010.01 | -0.02 | 150.00% (+0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.03 | -0.15 | 82.35% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
